GEOS Q1 2026 Earnings Adjusted Loss of 086 Per Share Stock Declines CCK Q1 2026 Earnings EPS Surpasses Expectations Amid Cost Discipline Prime Medicine Inc PRME Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Development Phase GROV Q1 2026 Earnings Significant EPS Beat Amid Cost Discipline TransCode Therapeutics Q4 2024 Earnings WiderthanExpected Loss Reflects ClinicalStage Investment RTX Q1 2026 Earnings EPS Surges Past Estimates with 161 Beat